He is passionate about bringing the most advanced regenerative treatments to his patients to help them achieve a new level of health and vitality
T2DM patients who were prescribed semaglutide were significantly less likely to be diagnosed with AD during a three-year follow-up visit as compared with those prescribed other antidiabetic medications, irrespective of sex, gender, and obesity
Effects of glucagon-like peptide-1 receptor agonists on cardiovascular outcomes in high-risk type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
Gcel provides an energizing boost to the liver and the entire body during detoxification
GLP-1 Wegovy , a transformative approach to sustainable weight loss Lose up to 15% of your body weight* FDA-approved for weight loss Aids in helping you feel fuller, longer 1 Get started *In a 68-week placebo-controlled study of 1,961 obese and overweight non-diabetic adults with weight-related conditions, the treatment group receiving semaglutide experienced a mean body weight loss of 15%, compared to 2% of the placebo group